Completed
BRENTUXIMAB VEDOTIN as Pre-ASCT Induction Therapy in R/R HL Patients Non Responding to IGEV
NCT02244021
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +7 more
- Locations
-
- Istituto di Ematologia "L. & A. Seragnoli" , Policlinico S. Orsola Malpighi Bologna, Italy
- Ematologia, IRCCS AOU San Martino-IST Genova, Italy
- Ematologia Ospedale Vito Fazzi Lecce, Italy
- Ematologia e Unità BMT IRCCS Istituto Nazionale dei Tumori Milan, Italy